Cardio Diagnostics Holdings (CDIOW) Enterprise Value (2021 - 2025)
Historic Enterprise Value for Cardio Diagnostics Holdings (CDIOW) over the last 5 years, with Q3 2025 value amounting to -$6.4 million.
- Cardio Diagnostics Holdings' Enterprise Value fell 22055.13% to -$6.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.4 million, marking a year-over-year decrease of 22055.13%. This contributed to the annual value of -$7.8 million for FY2024, which is 50984.39% down from last year.
- Per Cardio Diagnostics Holdings' latest filing, its Enterprise Value stood at -$6.4 million for Q3 2025, which was down 22055.13% from -$8.0 million recorded in Q2 2025.
- In the past 5 years, Cardio Diagnostics Holdings' Enterprise Value ranged from a high of -$9681.0 in Q3 2021 and a low of -$74.7 million during Q2 2022
- Moreover, its 5-year median value for Enterprise Value was -$5.7 million (2023), whereas its average is -$18.8 million.
- Per our database at Business Quant, Cardio Diagnostics Holdings' Enterprise Value crashed by 76983483.11% in 2022 and then surged by 9513.04% in 2023.
- Quarter analysis of 5 years shows Cardio Diagnostics Holdings' Enterprise Value stood at -$65.5 million in 2021, then surged by 93.71% to -$4.1 million in 2022, then skyrocketed by 68.83% to -$1.3 million in 2023, then plummeted by 509.84% to -$7.8 million in 2024, then rose by 18.81% to -$6.4 million in 2025.
- Its last three reported values are -$6.4 million in Q3 2025, -$8.0 million for Q2 2025, and -$9.7 million during Q1 2025.